FDA Approval of First Digital Pill Based on ' Weak Evidence ' FDA Approval of First Digital Pill Based on ' Weak Evidence '

A review of the data that led to the FDA approval of digital aripiprazole suggests the evidence is weak and raises concerns about technology-enhanced products to ' evergreen ' drugs going off patent.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news
More News: Abilify | Psychiatry